Pattern of antidiabetic drugs use in type-2 diabetic patients in a medicine outpatient clinic of a tertiary care teaching hospital

Bela Patel, Bhavit Oza, Kamlesh P. Patel, Supriya D. Malhotra, Varsha J. Patel

Abstract


Background: Diabetes mellitus (DM) is an important public health problem in developing countries. Drug utilisation study of antidiabetic agents is of paramount importance to promote rational drug use in diabetics and make available valuable information for the healthcare team. The aim of study was to investigate the drug utilization pattern in type-2 diabetic patients.

Methods: A prospective, cross-sectional study was carried out in medicine outpatient clinic of tertiary care hospital, Ahmedabad for eight weeks. Patients with type-2 diabetes and on drug therapy for at least one month were included. Patients’ socio-demographic and clinical data were noted in a pre-designed proforma. Data was analysed by using SPSS version 20 and Excel 2007.

Results: Total 114 patients were enrolled with mean (± standard deviation)
age and duration of diabetes of 56.8 ± 10.5 and 8.3 ± 9.4 years respectively. Male: Female ratio was 0.72:1. Mean fasting and postprandial blood glucose levels were 147.5 ± 73.1 and 215.6 ± 97.3 mg/dl respectively. Most common symptom was weakness/fatigue (77.2%). Hypertension (70.2%) was most common co-morbid illness. Mean number of drugs prescribed were 7.8 ± 2.5. Total numbers of patients receiving more than five drugs were 89.5%. Most commonly used drug group was biguanides (87.7%) followed by sulphonylureas (68.4%).

Conclusion: Metformin (biguanide) was the most utilized (87.7%) antidiabetic drug for type-2 diabetes. This study revealed that the pattern of antidiabetic prescription was rational and largely compliant with NICE (National Institute for Health and Clinical Excellence) guidelines.


Keywords


Diabetes, Blood glucose, Anti-diabetic drugs, Metformin

Full Text:

PDF

References


World Health Organization. Diabetes fact sheet. 2008. Available at http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed 17 December 2008.

Trplitt LC, Reasner AC, Isley LW, DiPiro JT, Talbert RL. Diabetes mellitus. In: Dipiro JT, Talbert RC, Matzke GR, Wells BG, Rosey LM, editors. Pharmacotherapy a pathophysiologic approach. 7th ed. New York: McGraw Hill; 2005. pp. 1333-67.

Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-7.

Sayed Aliul Hasan Abdi, Shobha Churi, YS Ravi Kumar. Study of drug utilization pattern of antihyperglycemic agents in a South Indian tertiary care teaching hospital. Indian J Pharmacol 2012 Mar-Apr; 44(2):210-4.

Adibe MO, Aguwa CN, Ukwe CV, Okonta JM, Udeogaranya PO. Outpatient Utilization Of Anti-Diabetic Drugs In The South Eastern Nigeria. Int J Drug Dev & Res, Sep-Dec 2009;1(1):27-36.

Vijayakumar S, Sasikala M, Mohammed Saleem TS, Gauthaman K. Prevalence of diabetes in Sikkim and Darjeeling district of west Bengal and role of risk factor associated with it- A preliminary survey IJCP 2008;I(3):36-40.

Afolayan AJ, Sunmonu TO, 2010. In vivo studies on antidiabetic plants used in South African herbal medicine. J Clin Biochem Nutr 2010;47:98-106.

Upadhyay DK, Palaian S, Ravi Shankar P, et al. Prescribing Pattern In Diabetic Outpatients In A Tertiary Care Teaching Hospital In Nepal. Journal of Clinical and Diagnostic Research 2007;3:248-55.

AbdulGafar O. Jimoh, Anas A. Sabir, Aminu Chika and Zuwaira Sani. Pattern of Antidiabetic Drugs Use in a Diabetic Outpatient Clinic of a Tertiary Health Institution in Sokoto, North-western Nigeria. Journal of Medical Sciences 2011;11:241-5.

Dr Faith S. Luyster, Dr Jacqueline Dunbar-Jacob. Sleep Quality and Quality of Life in Adults with Type 2 Diabetes. Diabetes Educ. 2011;37(3):347-55.

Mayur Patel, Ina M. Patel, Yash M. Patel, and Suresh K. Rathi. A Hospital-based Observational Study of Type 2 Diabetic Subjects from Gujarat, India. J Health Popul Nutr 2011 Jun;29(3):265-72.

Lisha Jenny John, Mohammed Arifulla, Jayadevan Sreedharan, Jayakumary Muttappallymyalil, Rajdeep Das, Jenny John et al. Age And Gender-Based Utilization Pattern of Antidiabetic Drugs In Ajman, UAE. Malaysian Journal of Pharmaceutical Sciences 2012;10(1):79-85.

Sayed Aliul Hasan Abdi, Shobha Churi, and Y.S. Ravi Kumar. Study of drug utilization pattern of antihyperglycemic agents in a South Indian tertiary care teaching hospital. Indian J Pharmacol. 2012 Mar-Apr;44(2):210-4.

R. Ramesh, Subash Vijaya Kumar, S. Gopinath, B.Gavaskar and G.Gandhiji. Diabetic knowledge of rural community and drug utilization pattern in a tertiary care hosptial. International Journal of Pharmacy & Life Sciences 2011;2(1):531-5.

Sutharson L, Hariharan RS, Vamsadhara C. Drug Utilization Study in Diabetology Outpatient Setting of a Tertiary Hospital. Indian J of Pharmacol 2003;35:237-40.

Sudha V, Shukla P, Patidar P, et al. Prescribing Pattern of Antidiabetic Drugs in Indore City Hospital Indian. Journal of Pharmaceutical Sciences 2008;70(5):637-40.

Boccuzzi SJ, Wogen J, Fox J, et al. Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population. Diabetes Care 2004;24(8):1411-5.

Johnson JA, Pohar SL, Secnik K. Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001. BMC Health Serv Res 2006;6:159.

Yurgin N, Secnik K, Lage MJ. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study. Clin Ther 2007;29(2):316-25.

De Pablos-Velasco PL, Martinez-Martin FJ, Molero R, et al. Pattern of prescription of hypoglycemic drugs in Gran Canaria (Canary Islands, Spain) and estimation of the prevalence of diabetes mellitus. Diabetes & Metabolism 2005;31(5):457-62.

Good CB. Polypharmacy in elderly patients with diabetes. Diabetes Spectrum 2002;15(4):240-8.

Sultana G, Kapur P, Aqil M, et al. Drug utilization of oral hypoglycemic agents in a university teaching hospital in India. J Clin Pharm Ther 2010;35(3):267-77.

Chiang CW, Chiu HF, Chens CY, et al. Trends in the use of oral antidiabetic drugs by outpatients in Taiwan: 1997–2003. Journal of Clinical Pharmacy and Therapeutics 2006;31:73-82.

Al Khaja KA, Sequeira RP, Mathur VS. Prescribing patterns and therapeutic implications for diabetic hypertension in Bahrain. Ann Pharmacother 2001;35(11):1350-9.

Xavier D, Nagarani MA, Srishyla MV. Drug utilization study of antihypertensives and antidiabetics in an Indian referral hospital. Indian J Pharmacol. 1999;31:241-2.

Lau GSN, Chan JCN, Chu PLM, Tse DCK, Critchley JAJH. Use of antidiabetic and antihypertensive drugs in hospital and outpatient settings in Hong Kong. Ann Pharmacother. 1996;30:232-7.

CDA, 2008. Clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Diabetes Association, http://www.diabetes.ca/files/cpg2008/cpg-2008.pdf.

IDF, 2005. Clinical guidelines task force: Global guideline for type 2 diabetes. International Diabetes Federation, Brussels, http://www.idf.org/webdata/ docs/IDF%20GGT2D.pdf.

NIHCE, 2010. Type 2 diabetes: The management in primary and secondary care (update). National Institute for Health and Clinical Excellence.

Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of hyperglycaemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care 2006;29:1963-72.

Intercontinental Marketing Service. Available at http://www.imshealth.com. Accessed 16 November 2007.